⌘K

Login Start Free

Home/Filings/4/0001209191-09-052601

4//SEC Filing

Standring David 4

Accession 0001209191-09-052601

CIK 0001093649other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 2:09 PM ET

Size

8.0 KB

Accession

0001209191-09-052601

Insider Transaction Report

Form 4

Period: 2009-11-11

IDENIX PHARMACEUTICALS INCIDIX

Standring David

EVP, Biology

Transactions

Exercise/Conversion
Employee Stock Option (right to buy)
2009-11-11−15,000→ 0 total
Exercise: $1.00Exp: 2010-09-19→ Common Stock (15,000 underlying)
Exercise/Conversion
Common Stock
2009-11-11$1.00/sh+15,000$15,000→ 67,375 total

Holdings

Common Stock
(indirect: By Spouse)
200

Footnotes (1)

[F1]This option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeother

Related Parties

1

filerCIK 0001428085

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 2:09 PM ET
Size: 8.0 KB

View on SEC.gov